Walmart Inc. (NASDAQ:WMT) stock fell in Thursday’s premarket session despite the retail giant reporting better-than-expected third-quarter fiscal 2027 results and raising its full-year outlook again.

Earnings Snapshot

Adjusted earnings of 65 cents per share exceeded analyst expectations of 64 cents. The figure excludes an after-tax loss of 3 cents per share related to equity and other investments.

Revenue rose 5.2% year over year to $188.835 billion, topping the consensus estimate of $187.271 billion. On a constant-currency basis, revenue increased 4.5%.

Global e-commerce net sales increased 17%, accounting for 24% of total net sales. Membership and other income grew 20%, driven by a 17% increase in global membership fee revenue and higher miscellaneous income.

The gross profit rate expanded 28 basis points to 24.5%, reflecting a more favorable business and merchandise mix at Walmart U.S.

The timing of Flipkart’s Big Billion Days sales event also benefited Walmart International’s gross profit rate. However, lower fuel margins at Sam’s Club U.S. partially offset those gains.

On a constant-currency basis, adjusted operating income increased 5.5% year over year, outpacing net sales growth of 4.4%.

Stronger sales, higher gross margins, global membership growth and additional miscellaneous income drove the increase. However, expenses growing faster than sales limited those gains.

During Thursday’s earnings call, a Walmart executive warned that elevated diesel prices could prolong fuel and transportation cost pressures.

“We’ve had some cost pressures throughout the year on fuel and transportation. I think some of those will remain true as long as diesel fuel remains elevated,” the executive said.

Global inventory increased 8.1%, reflecting strategic initiatives, the timing of seasonal events and inflation-related cost increases.

Walmart repurchased $2.7 billion in shares during the quarter, leaving $22.4 billion under its share repurchase authorization.

Walmart U.S. Performance

Walmart U.S. net sales rose 3.6% year over year to $125 billion, while e-commerce sales increased 23%.

Excluding fuel, comparable sales grew 2.9%, driven by a 1.5% increase in transactions and a 1.4% rise in average transaction value.

Pharmacy deflation created a net headwind of approximately 70 basis points to comparable sales growth. Like-for-like inflation stood at 1.2%.

Store-fulfilled delivery grew more than 40%, supporting e-commerce growth. Meanwhile, marketplace sales jumped 49%, and the advertising business grew 37%.

Membership and other income surged 43%, reflecting double-digit Walmart+ membership revenue growth and higher miscellaneous income. The increase also included fees from the company’s bundled membership offering.

Walmart introduced a new $120 annual membership package in the U.S., combining Walmart+ and Sam’s Club Plus.

Walmart International Performance

Walmart International net sales increased 3.3% year over year to $34.7 billion on a constant-currency basis. Higher unit volumes and customer transactions drove growth across markets.

However, the timing of Flipkart’s Big Billion Days sales event reduced growth by approximately 500 basis points. Walmart expects a corresponding benefit in the fourth quarter.

E-commerce sales declined 2%, primarily due to the event’s timing.

Membership fee revenue jumped 29%, contributing to a 16.4% increase in membership and other income. Favorable currency movements boosted reported sales by $1.2 billion.

Walmart Raises Full-Year Outlook

Walmart raised its fiscal 2027 adjusted earnings forecast to $2.84-$2.89 per share from $2.80-$2.87. Analysts expect earnings of $2.88 per share.

The retailer also lifted its full-year revenue forecast to $741.01 billion-$743.13 billion from $734.66 billion-$741.72 billion. However, the revised range remains below the analyst consensus estimate of $752.65 billion.

Walmart expects fiscal 2027 net sales to increase 4.9% to 5.2% year over year.

Walmart forecast fourth-quarter sales of $199.236 billion to $201.142 billion, compared with the analyst consensus estimate of $200.106 billion.

GLP-1 Sales Benefit Narrows

Walmart’s weight-loss drug windfall is losing steam despite rising prescription volumes.

The retailer expects GLP-1 medications to deliver a 40% smaller boost to U.S. comparable sales growth this fiscal year than in each of the previous two years, as unfavorable pricing and shifts in product mix erode their sales contribution.

It expects GLP-1 medications to contribute approximately 60 basis points to fiscal 2027 U.S. comparable sales growth, excluding fuel. That compares with approximately 100 basis points in both fiscal 2025 and 2026.

Unfavorable pricing and product mix more than offset prescription volume growth, reducing the contribution from GLP-1 medications.

During the third quarter, pharmacy deflation and shifts from brand-name to generic prescriptions related to maximum fair price regulation created a headwind of approximately 125 basis points. Growth primarily from GLP-1 medications partially offset that pressure.

WMT Price Action: Walmart shares were down 1.04% at $126.03 during premarket trading on Thursday, according to Benzinga Pro data.

Photo via Shutterstock